BRPI0916774A2 - derivados de indolila e indazolila substituídos e usos dos mesmos - Google Patents
derivados de indolila e indazolila substituídos e usos dos mesmosInfo
- Publication number
- BRPI0916774A2 BRPI0916774A2 BRPI0916774A BRPI0916774A BRPI0916774A2 BR PI0916774 A2 BRPI0916774 A2 BR PI0916774A2 BR PI0916774 A BRPI0916774 A BR PI0916774A BR PI0916774 A BRPI0916774 A BR PI0916774A BR PI0916774 A2 BRPI0916774 A2 BR PI0916774A2
- Authority
- BR
- Brazil
- Prior art keywords
- substituted indolyl
- indazolyl derivatives
- indazolyl
- derivatives
- indolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8087508P | 2008-07-15 | 2008-07-15 | |
| PCT/EP2009/058480 WO2010006945A1 (en) | 2008-07-15 | 2009-07-06 | Substituted indolyl and indazolyl derivatives and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0916774A2 true BRPI0916774A2 (pt) | 2018-02-20 |
Family
ID=41130156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0916774A BRPI0916774A2 (pt) | 2008-07-15 | 2009-07-06 | derivados de indolila e indazolila substituídos e usos dos mesmos |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8198274B2 (pt) |
| EP (1) | EP2307008A1 (pt) |
| JP (1) | JP2011528005A (pt) |
| KR (1) | KR20110017007A (pt) |
| CN (1) | CN102099031A (pt) |
| AU (1) | AU2009272900B2 (pt) |
| BR (1) | BRPI0916774A2 (pt) |
| CA (1) | CA2730397A1 (pt) |
| IL (1) | IL210077A0 (pt) |
| MX (1) | MX2011000494A (pt) |
| WO (1) | WO2010006945A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011255456B2 (en) | 2010-05-21 | 2017-01-19 | Dignity Health Doing Business As St. Joseph's Hospital And Medical Center And Barrow Neurological Institute | 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence |
| ES2687095T3 (es) | 2010-05-21 | 2018-10-23 | Research Triangle Institute | Fenilimorfolinas y análogos de las mismas |
| US9890119B2 (en) | 2013-02-27 | 2018-02-13 | Shionogi & Co., Ltd. | Indole and azaindole derivative having AMPK-activating activity |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2646349B1 (fr) * | 1989-04-28 | 1994-04-01 | Roussel Uclaf | Derives du 4-phenylmethyl lh-indole, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant |
| JP4617299B2 (ja) * | 2003-03-03 | 2011-01-19 | アレイ バイオファーマ、インコーポレイテッド | ｐ３８阻害剤及びその使用法 |
| AU2004303461B2 (en) * | 2003-12-23 | 2011-04-28 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| BRPI0619263A2 (pt) | 2005-11-30 | 2011-09-27 | Hoffmann La Roche | indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis |
| DE102005059960A1 (de) * | 2005-12-15 | 2007-06-28 | Degussa Gmbh | Hochgefüllte Übergangs-Aluminiumoxid enthaltende Dispersion |
-
2009
- 2009-07-06 CA CA2730397A patent/CA2730397A1/en not_active Abandoned
- 2009-07-06 KR KR1020117000899A patent/KR20110017007A/ko not_active Application Discontinuation
- 2009-07-06 JP JP2011517857A patent/JP2011528005A/ja active Pending
- 2009-07-06 AU AU2009272900A patent/AU2009272900B2/en not_active Ceased
- 2009-07-06 MX MX2011000494A patent/MX2011000494A/es not_active Application Discontinuation
- 2009-07-06 CN CN2009801273516A patent/CN102099031A/zh active Pending
- 2009-07-06 EP EP09780168A patent/EP2307008A1/en not_active Withdrawn
- 2009-07-06 WO PCT/EP2009/058480 patent/WO2010006945A1/en active Application Filing
- 2009-07-06 BR BRPI0916774A patent/BRPI0916774A2/pt not_active IP Right Cessation
- 2009-07-15 US US12/460,199 patent/US8198274B2/en not_active Expired - Fee Related
-
2010
- 2010-12-16 IL IL210077A patent/IL210077A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009272900A1 (en) | 2010-01-21 |
| IL210077A0 (en) | 2011-02-28 |
| CA2730397A1 (en) | 2010-01-21 |
| EP2307008A1 (en) | 2011-04-13 |
| JP2011528005A (ja) | 2011-11-10 |
| AU2009272900B2 (en) | 2012-04-19 |
| KR20110017007A (ko) | 2011-02-18 |
| US8198274B2 (en) | 2012-06-12 |
| CN102099031A (zh) | 2011-06-15 |
| MX2011000494A (es) | 2011-02-25 |
| WO2010006945A1 (en) | 2010-01-21 |
| US20100016312A1 (en) | 2010-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0920927A2 (pt) | derivados de azaquinolinona e usos dos mesmos | |
| BRPI0908906A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
| BRPI0914682A2 (pt) | compostos de heteroarila e usos dos mesmos | |
| BRPI0815811A2 (pt) | Derivados de indol substituído e métodos de uso dos mesmos | |
| BRPI0912198A2 (pt) | anticorpos anti-fn14 e usos dos mesmos | |
| BR112012003709A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
| BRPI0910702A2 (pt) | polipeptídeos de fator ix modificados e usos dos mesmos | |
| BRPI0912480A2 (pt) | compostos de monoalquiltina de alta pureza e usos dos mesmos | |
| BRPI1014997A2 (pt) | compostos heteroarila e usos dos mesmos | |
| BRPI0909469A2 (pt) | compostos de oximetileno de arila e usos dos mesmos | |
| BRPI1010024A2 (pt) | derivados de aminopirrolidinona e uso dos mesmos | |
| BRPI0819909A2 (pt) | anticorpos antimesotelina e usos dos mesmos | |
| BRPI0922691A2 (pt) | conjugados de leptina e análogo de leptina e usos dos mesmos | |
| BR112012006501A2 (pt) | polipeptídios e usos dos mesmos | |
| BRPI0922790A2 (pt) | peptídeos de ligação sparc e usos dos mesmos | |
| BRPI1009455A2 (pt) | anticorpos anti-c40 e usos dos mesmos | |
| BRPI0923283A2 (pt) | conjugados terapêuticos de peptídeo e usos dos mesmos | |
| BRPI0922807A2 (pt) | imonuglobulinas de domínio variável duplo e usos dos mesmos | |
| DOP2010000260A (es) | Derivado heterociclico fusionado y su uso | |
| BR112012015873A2 (pt) | antagonistas de receptores ccr2 e usos dos mesmos | |
| BR112013015592A8 (pt) | derivados de biciclo-[3.2.1]-octilamida e usos dos mesmos | |
| BRPI0920209A2 (pt) | conjugados de agonistas de glp-1 e usos dos mesmos | |
| BRPI0922689A2 (pt) | conjugados de neurotensina ou análogos de neurotensina e usos dos mesmos | |
| BRPI0720909A2 (pt) | derivados de isoquinolina e isoquinolinona substituídos | |
| ATE549340T1 (de) | Spiroindolinon-derivate als mdm2-p53 inhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |